영양유전체학 시장 : 제품 유형별, 용도별, 최종사용자별 - 세계 기회 분석과 산업 예측(2023-2032년)

Nutrigenetics studies the presence of a particular gene variant or polymorphism that in most cases merely connotes a predisposition to a particular disease process that may be prevented through a complex interplay of environmental and behavioral factors such as a personalized nutrition. Nutrigenomics refers to the study of the effects of specific nutrients or nutraceuticals on the expression of an individual's genetic makeup.

Rising prevalence of chronic diseases such as obesity, diabetes, and cardiovascular diseases is driving the growth of the nutrigenomics testing market. Over the past decade, rapid advancements in omic technologies such as proteomics, genomics, and metabolomics are combining with advanced bioinformatics to be broadly used for identifying diseases based on protein pathways. Currently, the findings of nutrigenomics have been used to some extent to treat diseases with a diet component like diabetes, cancer, and obesity, significantly boosting the nutrigenomics testing market size.

Accuracy and reliability of the nutrigenomic test findings is one of the major concerns for most of the consumers. Direct-to-consumer tests including nutrigenomic tests have varying levels of evidence that support their claims. Some direct-to-consumer tests have more scientific and clinical data to support the information provided in the test, while other tests do not have as much supporting data. Furthermore, disagreements in the clinical community about the role that different genetic variants are contributing to the disease is another reason affecting the accuracy and reliability of the test. Moreover, not all variants contribute to an individual's risk of getting a disease or condition, so it is important that customers understand that a negative result does not mean that the individual is free from the risk of developing a particular disease or condition. As different companies test for the different set of variants, therefore the same nutrigenomics tests might provide different results for the same disease. Thus, customers need to use their own judgment while ordering and interpreting the results from nutrigenomic tests. Therefore, nutrigenomics test results are not considered as accurate and reliable, further hampering the overall demand.

Sport nutrigenomics is another significant opportunity for nutrigenomics testing market. Thus, athletes are looking for tailor-made diets for improving their health status. Personalized nutrition in athletic populations aims in optimizing health, body composition, and exercise performance by targeting dietary recommendations to an individual's genetic profile. Sport dietitians and nutritionists have long been skilled at placing additional analysis on the one-size-fits-all general population dietary guidelines to accommodate various sporting populations. However, generic 'one-size-fits-all' recommendations still remain. Genetic differences are known to impact absorption, metabolism, uptake, utilization, and excretion of nutrients and food bio actives, which ultimately affects a number of metabolic pathways. Nutrigenomics and nutrigenetics are experimental approaches that use genomic information and genetic testing technologies to examine the role of individual genetic differences in modifying an athlete's response to nutrients and other food components. Although there have been few randomized, controlled trials examining the effects of genetic variation on performance in response to an ergogenic aid, there is a growing foundation of research linking gene-diet interactions on biomarkers of nutritional status, which impact exercise and sport performance. This foundation forms the basis from which the field of sport nutrigenomics continues to develop.

The COVID-19 pandemic had significant impacts on the nutrigenomics testing market growth. The pandemic introduced many new users to telehealth and further reinforced its benefits to potential competitors. In turn, the COVID-19 pandemic has also driven additional industry consolidation or collaboration within the nutrigenomics market. Furthermore, the COVID-19 pandemic, and its resulting changes in consumer behavior and expectations, has also caused various traditional healthcare providers to evaluate and pursue telehealth options that can be paired with their in-person capabilities. Also, telehealth awareness, acceptance, and usage have been positively impacted by the COVID-19 pandemic, leading to increased consumer acceptance of virtual care. Thus, the pandemic led to an increase in the utilization of telehealth services, which is anticipated to boost the nutrigenomics market in the post-pandemic period.

Some of the companies operating in the cybersecurity in banking market are Ancestry, Nutrigenomix, 23andMe Inc., DNAfit, GX Sciences Inc., Xcode Life, Koninklijke DSM N.V. (Royal DSM), BASF SE, Danone S.A., and The Gene Box.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nutrigenomics market analysis from 2022 to 2032 to identify the prevailing nutrigenomics market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the nutrigenomics market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global nutrigenomics market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Consumer Buying Behavior Analysis
• End user preferences and pain points
• Investment Opportunities
• Upcoming/New Entrant by Regions
• Technology Trend Analysis
• Go To Market Strategy
• Market share analysis of players by products/segments
• Pain Point Analysis
• Regulatory Guidelines
• Strategic Recommedations
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Criss-cross segment analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Market share analysis of players at global/region/country level
• SWOT Analysis

Key Market Segments

By Product Type

• Reagents and Kits
• Services

By Applications

• Diabetes
• Cardiovascular Diseases
• Cancer Research
• Obesity

By End User

• Online Platforms
• Hospitals and Clinics
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Cura Integrative Medicine
• Holistic Health
• Metagenics, Inc.
• GX Sciences Inc.
• The Gene Box
• Nutrigenomix Inc.
• Xcode Life
• DNA Life
• Interleukin Genetics
• Genova Diagnostics

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
• 3.4. Market dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities
• 3.5. Market Share Analysis
• 3.6. Brand Share Analysis
• 3.7. Value Chain Analysis
• 3.8. Regulatory Guidelines
• 3.9. Key Regulation Analysis

CHAPTER 4: NUTRIGENOMICS MARKET, BY PRODUCT TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Reagents and Kits
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Services
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country

CHAPTER 5: NUTRIGENOMICS MARKET, BY APPLICATIONS

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Obesity
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Diabetes
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Cardiovascular Diseases
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Cancer Research
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country

CHAPTER 6: NUTRIGENOMICS MARKET, BY END USER

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Online Platforms
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Hospitals and Clinics
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Others
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: NUTRIGENOMICS MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by Product Type
  • 7.2.3. Market size and forecast, by Applications
  • 7.2.4. Market size and forecast, by End User
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Market size and forecast, by Product Type
    • 7.2.5.1.2. Market size and forecast, by Applications
    • 7.2.5.1.3. Market size and forecast, by End User
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Market size and forecast, by Product Type
    • 7.2.5.2.2. Market size and forecast, by Applications
    • 7.2.5.2.3. Market size and forecast, by End User
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Market size and forecast, by Product Type
    • 7.2.5.3.2. Market size and forecast, by Applications
    • 7.2.5.3.3. Market size and forecast, by End User
• 7.3. Europe
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by Product Type
  • 7.3.3. Market size and forecast, by Applications
  • 7.3.4. Market size and forecast, by End User
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Market size and forecast, by Product Type
    • 7.3.5.1.2. Market size and forecast, by Applications
    • 7.3.5.1.3. Market size and forecast, by End User
    • 7.3.5.2. UK
    • 7.3.5.2.1. Market size and forecast, by Product Type
    • 7.3.5.2.2. Market size and forecast, by Applications
    • 7.3.5.2.3. Market size and forecast, by End User
    • 7.3.5.3. France
    • 7.3.5.3.1. Market size and forecast, by Product Type
    • 7.3.5.3.2. Market size and forecast, by Applications
    • 7.3.5.3.3. Market size and forecast, by End User
    • 7.3.5.4. Spain
    • 7.3.5.4.1. Market size and forecast, by Product Type
    • 7.3.5.4.2. Market size and forecast, by Applications
    • 7.3.5.4.3. Market size and forecast, by End User
    • 7.3.5.5. Italy
    • 7.3.5.5.1. Market size and forecast, by Product Type
    • 7.3.5.5.2. Market size and forecast, by Applications
    • 7.3.5.5.3. Market size and forecast, by End User
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Market size and forecast, by Product Type
    • 7.3.5.6.2. Market size and forecast, by Applications
    • 7.3.5.6.3. Market size and forecast, by End User
• 7.4. Asia-Pacific
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by Product Type
  • 7.4.3. Market size and forecast, by Applications
  • 7.4.4. Market size and forecast, by End User
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. China
    • 7.4.5.1.1. Market size and forecast, by Product Type
    • 7.4.5.1.2. Market size and forecast, by Applications
    • 7.4.5.1.3. Market size and forecast, by End User
    • 7.4.5.2. Japan
    • 7.4.5.2.1. Market size and forecast, by Product Type
    • 7.4.5.2.2. Market size and forecast, by Applications
    • 7.4.5.2.3. Market size and forecast, by End User
    • 7.4.5.3. India
    • 7.4.5.3.1. Market size and forecast, by Product Type
    • 7.4.5.3.2. Market size and forecast, by Applications
    • 7.4.5.3.3. Market size and forecast, by End User
    • 7.4.5.4. South Korea
    • 7.4.5.4.1. Market size and forecast, by Product Type
    • 7.4.5.4.2. Market size and forecast, by Applications
    • 7.4.5.4.3. Market size and forecast, by End User
    • 7.4.5.5. Australia
    • 7.4.5.5.1. Market size and forecast, by Product Type
    • 7.4.5.5.2. Market size and forecast, by Applications
    • 7.4.5.5.3. Market size and forecast, by End User
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Market size and forecast, by Product Type
    • 7.4.5.6.2. Market size and forecast, by Applications
    • 7.4.5.6.3. Market size and forecast, by End User
• 7.5. LAMEA
  • 7.5.1. Key market trends, growth factors and opportunities
  • 7.5.2. Market size and forecast, by Product Type
  • 7.5.3. Market size and forecast, by Applications
  • 7.5.4. Market size and forecast, by End User
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Market size and forecast, by Product Type
    • 7.5.5.1.2. Market size and forecast, by Applications
    • 7.5.5.1.3. Market size and forecast, by End User
    • 7.5.5.2. UAE
    • 7.5.5.2.1. Market size and forecast, by Product Type
    • 7.5.5.2.2. Market size and forecast, by Applications
    • 7.5.5.2.3. Market size and forecast, by End User
    • 7.5.5.3. Saudi Arabia
    • 7.5.5.3.1. Market size and forecast, by Product Type
    • 7.5.5.3.2. Market size and forecast, by Applications
    • 7.5.5.3.3. Market size and forecast, by End User
    • 7.5.5.4. South Africa
    • 7.5.5.4.1. Market size and forecast, by Product Type
    • 7.5.5.4.2. Market size and forecast, by Applications
    • 7.5.5.4.3. Market size and forecast, by End User
    • 7.5.5.5. Rest of LAMEA
    • 7.5.5.5.1. Market size and forecast, by Product Type
    • 7.5.5.5.2. Market size and forecast, by Applications
    • 7.5.5.5.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product mapping of top 10 player
• 8.4. Competitive dashboard
• 8.5. Competitive heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Cura Integrative Medicine
  • 9.1.1. Company overview
  • 9.1.2. Key executives
  • 9.1.3. Company snapshot
• 9.2. Holistic Health
  • 9.2.1. Company overview
  • 9.2.2. Key executives
  • 9.2.3. Company snapshot
• 9.3. Metagenics, Inc.
  • 9.3.1. Company overview
  • 9.3.2. Key executives
  • 9.3.3. Company snapshot
• 9.4. GX Sciences Inc.
  • 9.4.1. Company overview
  • 9.4.2. Key executives
  • 9.4.3. Company snapshot
• 9.5. The Gene Box
  • 9.5.1. Company overview
  • 9.5.2. Key executives
  • 9.5.3. Company snapshot
• 9.6. Nutrigenomix Inc.
  • 9.6.1. Company overview
  • 9.6.2. Key executives
  • 9.6.3. Company snapshot
• 9.7. Xcode Life
  • 9.7.1. Company overview
  • 9.7.2. Key executives
  • 9.7.3. Company snapshot
• 9.8. DNA Life
  • 9.8.1. Company overview
  • 9.8.2. Key executives
  • 9.8.3. Company snapshot
• 9.9. Interleukin Genetics
  • 9.9.1. Company overview
  • 9.9.2. Key executives
  • 9.9.3. Company snapshot
• 9.10. Genova Diagnostics
  • 9.10.1. Company overview
  • 9.10.2. Key executives
  • 9.10.3. Company snapshot